2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.
Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.
Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.
According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.
Related Content: